Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Neurochem Res ; 43(8): 1671-1682, 2018 Aug.
Article in English | MEDLINE | ID: mdl-29936569

ABSTRACT

The relationships between seizures, neuronal death, and epilepsy remain one of the most disputed questions in translational neuroscience. Although it is broadly accepted that prolonged and repeated seizures cause neuronal death and epileptogenesis, whether brief seizures can produce a mild but similar effect is controversial. In the present work, using a rat pentylenetetrazole (PTZ) model of seizures, we evaluated how a single episode of clonic-tonic seizures affected the viability of neurons in the hippocampus, the area of the brain most vulnerable to seizures, and morphological changes in the hippocampus up to 1 week after PTZ treatment (recovery period). The main findings of the study were: (1) PTZ-induced seizures caused the transient appearance of massively shrunken, hyperbasophilic, and hyperelectrondense (dark) cells but did not lead to detectable neuronal cell loss. These dark neurons were alive, suggesting that they could cope with seizure-related dysfunction. (2) Neuronal and biochemical alterations following seizures were observed for at least 1 week. The temporal dynamics of the appearance and disappearance of dark neurons differed in different zones of the hippocampus. (3) The numbers of cells with structural and functional abnormalities in the hippocampus after PTZ-induced seizures decreased in the following order: CA1 > CA3b,c > hilus > dentate gyrus. Neurons in the CA3a subarea were most resistant to PTZ-induced seizures. These results suggest that even a single seizure episode is a potent stressor of hippocampal neurons and that it can trigger complex neuroplastic changes in the hippocampus.


Subject(s)
Hippocampus/pathology , Hippocampus/physiopathology , Neurons/metabolism , Seizures/pathology , Seizures/physiopathology , Animals , Antigens, Nuclear/metabolism , Caspase 3/metabolism , Cell Death/physiology , Cell Survival/physiology , Excitatory Amino Acid Transporter 1/metabolism , GABA Plasma Membrane Transport Proteins/metabolism , Male , Nerve Tissue Proteins/metabolism , Neurons/pathology , Pentylenetetrazole , Rats, Wistar , Seizures/chemically induced
2.
Neuroscience ; 327: 146-55, 2016 07 07.
Article in English | MEDLINE | ID: mdl-27109923

ABSTRACT

Temporal lobe epilepsy (TLE) is the most common type of epilepsy in humans. The lithium-pilocarpine model in rodents reproduces some of the main features of human TLE. Three-week-old Wistar rats were used in this study. The changes in AMPA receptor subunit composition were investigated in several brain areas, including the medial prefrontal cortex (mPFC), the temporal cortex (TC), and the dorsal (DH) and ventral hippocampus (VH) during the first week following pilocarpine-induced status epilepticus (PILO-induced SE). In the hippocampus, GluA1 and GluA2 mRNA expression slightly decreased after PILO-induced SE and returned to the initial level on the seventh day. We did not detect any significant changes in mRNA expression of the GluA1 and GluA2 subunits in the TC, whereas in the mPFC we observed a significant increase of GluA1 mRNA expression on the third day and a decrease in GluA2 mRNA expression during the entire first week. Accordingly, the GluA1/GluA2 expression ratio increased in the mPFC, and the functional properties of the pyramidal cell excitatory synapses were disturbed. Using whole-cell voltage-clamp recordings, we found that on the third day following PILO-induced SE, isolated mPFC pyramidal neurons showed an inwardly rectifying current-voltage relation of kainate-evoked currents, suggesting the presence of GluA2-lacking calcium-permeable AMPARs (CP-AMPARs). IEM-1460, a selective antagonist of CP-AMPARs, significantly reduced the amplitude of evoked EPSC in pyramidal neurons from mPFC slices on the first and third days, but not on the seventh day. The antagonist had no effects on EPSC amplitude in slices from control animals. Thus, our data demonstrate that PILO-induced SE affects subunit composition of AMPARs in different brain areas, including the mPFC. SE induces transient (up to few days) incorporation of CP-AMPARs in the excitatory synapses of mPFC pyramidal neurons, which may disrupt normal circuitry functions.


Subject(s)
Excitatory Postsynaptic Potentials/drug effects , Neocortex/drug effects , Receptors, AMPA/metabolism , Status Epilepticus/drug therapy , Synapses/drug effects , Animals , Disease Models, Animal , Hippocampus/metabolism , Neocortex/metabolism , Pilocarpine/toxicity , Pyramidal Cells/drug effects , Pyramidal Cells/metabolism , Rats, Wistar , Receptors, AMPA/drug effects , Status Epilepticus/chemically induced , Synapses/physiology
3.
J Neurosci Res ; 93(3): 454-65, 2015 Mar.
Article in English | MEDLINE | ID: mdl-25359451

ABSTRACT

Alterations in inhibitory and excitatory neurotransmission play a central role in the etiology of epilepsy, with overstimulation of glutamate receptors influencing epileptic activity and corresponding neuronal damage. N-methyl-D-aspartate (NMDA) receptors, which belong to a class of ionotropic glutamate receptors, play a primary role in this process. This study compared the anticonvulsant properties of two NMDA receptor channel blockers, memantine and 1-phenylcyclohexylamine (IEM-1921), in a pentylenetetrazole (PTZ) model of seizures in rats and investigated their potencies in preventing PTZ-induced morphological changes in the brain. The anticonvulsant properties of IEM-1921 (5 mg/kg) were more pronounced than those of memantine at the same dose. IEM-1921 and memantine decreased the duration of convulsions by 82% and 37%, respectively. Both compounds were relatively effective at preventing the tonic component of seizures but not myoclonic seizures. Memantine significantly reduced the lethality caused by PTZ-induced seizures from 42% to 11%, and all animals pretreated with IEM-1921 survived. Morphological examination of the rat brain 24 hr after administration of PTZ revealed alterations in the morphology of 20-25% of neurons in the neocortex and the hippocampus, potentially induced by excessive glutamate. The expression of the excitatory amino acid transporter 1 protein was increased in the hippocampus of the PTZ-treated rats. However, dark neurons did not express caspase-3 and were immunopositive for the neuronal nuclear antigen protein, indicating that these neurons were alive. Both NMDA antagonists prevented neuronal abnormalities in the brain. These results suggest that NMDA receptor channel blockers might be considered possible neuroprotective agents for prolonged seizures or status epilepticus leading to neuronal damage.


Subject(s)
Brain/drug effects , Excitatory Amino Acid Antagonists/pharmacology , Neurons/drug effects , Receptors, N-Methyl-D-Aspartate/antagonists & inhibitors , Seizures/prevention & control , Animals , Brain/metabolism , Brain/pathology , Caspase 3/metabolism , Cell Shape/drug effects , Cyclohexylamines/pharmacology , Cyclohexylamines/therapeutic use , Excitatory Amino Acid Antagonists/therapeutic use , Male , Memantine/pharmacology , Memantine/therapeutic use , Neurons/metabolism , Neurons/pathology , Pentylenetetrazole , Rats , Rats, Wistar , Seizures/chemically induced , Seizures/metabolism , Seizures/pathology
4.
Neurosci Lett ; 451(1): 29-33, 2009 Feb 13.
Article in English | MEDLINE | ID: mdl-19111901

ABSTRACT

9-Aminoacridine is known as "foot-in-the-door" NMDA receptor channel blocker because its binding prevents channel closure. Structural determinants of this mechanism of block were studied using a series of 9-aminoacridine derivatives. Experiments were performed on native NMDA receptors of hippocampal pyramidal neurons, isolated from rat brain slices. The use-dependence of block and kinetics of recovery from block were used to characterize mechanism of block produced by the compounds. Modifications, which preserve the flat structure of the tricyclic 9-aminoacridine moiety, affect blocking activity and kinetics but not the foot-in-the-door mechanism. On the contrary, disruption of the flat structure changes the mechanism of block to trapping. It is concluded that flat aromatic structure is one of the critical determinants of the action mechanism of 9-aminoacridine.


Subject(s)
Aminacrine/analogs & derivatives , Aminacrine/pharmacology , Hippocampus/drug effects , Ion Channel Gating/drug effects , Pyramidal Cells/drug effects , Receptors, N-Methyl-D-Aspartate/drug effects , Synaptic Membranes/drug effects , Aminacrine/chemistry , Animals , Animals, Newborn , Dose-Response Relationship, Drug , Excitatory Amino Acid Antagonists/chemistry , Excitatory Amino Acid Antagonists/pharmacology , Glutamic Acid/metabolism , Hippocampus/metabolism , Ion Channel Gating/physiology , Kinetics , Molecular Structure , Organ Culture Techniques , Patch-Clamp Techniques , Pyramidal Cells/metabolism , Rats , Receptors, N-Methyl-D-Aspartate/metabolism , Synaptic Membranes/metabolism , Synaptic Transmission/drug effects , Synaptic Transmission/physiology
SELECTION OF CITATIONS
SEARCH DETAIL
...